Menveo

Indicated For

Invasive meningococcal disease

About This Medication

# GSK Patient Assistance Program Patient Guide: How to Get Menveo at Low or No Cost Menveo is a meningococcal conjugate vaccine manufactured by GlaxoSmithKline Biologicals (GSK) that protects against serious infections from Neisseria meningitidis serogroups A, C, Y, and W-135. The **GSK Patient Assistance Program**, managed by the independent GSK Patient Access Programs Foundation, provides eligible patients with certain GSK vaccines like Menveo at no cost.[1] ## About Menveo **Menveo** is recommended for adolescents and adults at increased risk of meningococcal disease, including travelers to high-risk areas, people with certain medical conditions like asplenia or complement deficiencies, and during disease outbreaks. It works by conjugating oligosaccharides from the bacterial capsule to a diphtheria CRM197 protein carrier, triggering a strong immune response. Administered as a single intramuscular dose (0.5 mL), it is typically given to individuals aged 2 months through 55 years, depending on the indication. Unlike polysaccharide vaccines, Menveo's conjugate technology improves immunogenicity, especially in younger children, and may provide longer-lasting protection. Common side effects include injection site pain, fatigue, headache, and fever, which are usually mild and resolve quickly. Always consult your healthcare provider to confirm if Menveo is right for you and to discuss any precautions, such as avoiding it in those with severe allergies to diphtheria toxoid or latex (in the syringe tip cap).[1] ## Who Qualifies for the Program? The GSK Patient Assistance Program targets patients facing financial hardship who cannot afford GSK medicines and vaccines. While specific details for Menveo are not fully outlined in available resources, general eligibility focuses on uninsured or underinsured individuals with limited income. Key factors include: - Lack of prescription drug coverage or insurance that does not adequately cover the vaccine. - Household income below program thresholds (typically aligned with Federal Poverty Level, or FPL, though exact percentages for GSK are not specified here). - U.S. residency. The program is charitable and separate from GSK commercial operations, ensuring no cost for approved vaccines provided directly to eligible patients.[1] Facilities serving low-income populations, like clinics, may also qualify for bulk supplies. ## Income Eligibility Breakdown GSK does not publicly detail exact income thresholds for Menveo in the provided information, but patient assistance programs like this often use FPL guidelines (e.g., 400-500% of FPL). Contact GSK directly for current limits. Here's a general **2026 FPL table** for reference (based on U.S. HHS guidelines; actual program may vary): | Household Size | 100% FPL | 400% FPL | 500% FPL | |----------------|----------|----------|----------| | 1 (Individual) | $15,060 | $60,240 | $75,300 | | 2 (Couple) | $20,440 | $81,760 | $102,200| | 3 | $25,820 | $103,280| $129,100| | 4 | $31,200 | $124,800| $156,000| *Add ~$5,380 per additional person for FPL calculations. Notes: Thresholds adjust annually; Alaska/Hawaii have higher limits. Programs may exclude certain income sources or allow exceptions for hardships.*[3] ## Insurance Requirements The program is primarily for **uninsured patients** or those whose insurance does not cover Menveo. If you have Medicare Part D, it may cover vaccines like Menveo, but with potential out-of-pocket costs until reaching the $2,100 cap in 2026. Commercially insured patients typically do not qualify, but check for gaps in coverage. Medicaid-eligible children may access free vaccines via the Vaccines for Children (VFC) program at participating providers, not through GSK PAP.[4] Provide proof of insurance status (or lack thereof) during application.[1][3] ## Step-by-Step Application Process 1. **Confirm Eligibility**: Discuss with your doctor if Menveo is prescribed and if you qualify financially. Visit gskforyou.com or call the program.[1] 2. **Gather Documents**: Prepare proof of income (tax returns, pay stubs, W-2s), residency (utility bill), insurance status (denial letter if applicable), and prescription.[1] 3. **Get Application**: Download from gskforyou.com/programs/patient-assistance-program/ or request by phone. Your doctor may need to complete a portion.[1] 4. **Submit**: Mail, fax, or apply online/phone. Include all required docs to avoid delays.[1] 5. **Follow Up**: Track status via phone. Approval means free vaccine shipped to your provider or home.[1] ## Timeline and Delivery Processing typically takes 2-4 weeks, though urgent cases may be expedited. Once approved, Menveo is delivered at no cost via mail to your healthcare provider or directly, depending on program options. Vaccines require proper cold-chain handling, so expect provider administration. Replenishments for facilities occur periodically.[1][4] ## Alternatives if Denied - **VFC Program**: Free Menveo for eligible uninsured/underinsured kids at VFC sites.[4] - **State Programs**: Check state pharmaceutical assistance via Department of Aging.[3] - **GoodRx Discounts**: Up to 80% off at pharmacies; printable coupons.[3] - **Merck/Pfizer Programs**: If considering alternatives, though Menveo is GSK.[2][6] - **Medicare Savings**: Part D or Extra Help for low-income seniors.[3] - **Federally Qualified Health Centers**: Often provide vaccines to uninsured.[4] Appeal denials with additional hardship proof. Consult providers for boosters or alternatives like MenQuadfi (if appropriate). ## Disclaimer This guide is for informational purposes based on publicly available data as of 2026 and is not medical or financial advice. Eligibility, terms, and availability can change; contact GSK directly at gskforyou.com or their support line for latest details. Always verify with your healthcare provider. GSK makes no guarantees of approval. Word count: 942.

Program information last verified: March 30, 2026